1
Robin F B Turner, Douglas G Kilburn, Michael R Phelps: Biosensor and interface membrane. The University of British Columbia University Industry Liaison Office, Christensen O Connor Johnson & Kindness PLLC, April 29, 1997: US05624537 (487 worldwide citation)

A regenerable biosensor probe adapted for positioning in a bioreactor comprises a selectively permeable interface membrane, a porous protein-receiving matrix adjacent to the interface membrane, an indicating electrode, an inlet conduit through which fresh protein conjugate may flow to the protein-re ...


2
Krystal Gerald, Ong Christopher, Mui Alice: Compositions and methods for treating myelosuppression. British Columbia Cancer Agency Branch, The University Of British Columbia University Industry Liaison Office, Krystal Gerald, Ong Christopher, Mui Alice, CHATTERJEE Alakananda, February 28, 2008: WO/2008/022468 (2 worldwide citation)

The invention provides, in part, compositions and methods for protecting a hemopoietic cell, or for treating myelosuppression, in a subject in need thereof, by administering an effective amount of an inhibitor of a SH2-containing inositol-5'-phosphatase.


3
Sara Badiei, Septimiu Edmund Salcudean, Seyedeh Sara Mahdavi: Method for automated delineation of contours of tissue in medical images. The University of British Columbia University Industry Liaison Office, Jeffer Mangels Butler & Mitchell, September 25, 2012: US08275182

The present invention relates to a method for delineating the contour of an object in captured medical images by first transforming the shape of the object into a simple geometric shape that is more computationally tractable than the shape of the object. After the contour of the transformed shape is ...


4
Johnson Karl F, Defrees Shawn, Withers Stephen, Vaughan Mark: Mutant endoglycoceramidases with enhanced synthetic activity. Neose Technologies, The University Of British Columbia University Industry Liaison Office, Johnson Karl F, Defrees Shawn, Withers Stephen, Vaughan Mark, WAHLSTEN Jennifer L, December 15, 2005: WO/2005/118798

The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mu ...


5
MUTANT ENDOGLYCOCERAMIDASES WITH ENHANCED SYNTHETIC ACTIVITY. The University of British Columbia University Industry Liaison Office, Seneb BioSciences, May 29, 2014: US20140147891-A1

The present invention relates to a novel endoglycoceramidase whose hydrolytic activity has been substantially reduced or eliminated, such that the enzyme is useful for synthesis of glycolipids from a monosaccharide or oligosaccharide and a ceramide. More specifically, the endoglycoceramidase is a mu ...